Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment
- PMID: 31120872
- PMCID: PMC6550419
- DOI: 10.1371/journal.pntd.0007436
Wuchereria bancrofti-infected individuals harbor distinct IL-10-producing regulatory B and T cell subsets which are affected by anti-filarial treatment
Abstract
Despite worldwide mass drug administration, it is estimated that 68 million individuals are still infected with lymphatic filariasis with 19 million hydrocele and 17 million lymphedema reported cases. Despite the staggering number of pathology cases, the majority of LF-infected individuals do not develop clinical symptoms and present a tightly regulated immune system characterized by higher frequencies of regulatory T cells (Treg), suppressed proliferation and Th2 cytokine responses accompanied with increased secretion of IL-10, TGF-β and infection-specific IgG4. Nevertheless, the filarial-induced modulation of the host`s immune system and especially the role of regulatory immune cells like regulatory B (Breg) and Treg during an ongoing LF infection remains unknown. Thus, we analysed Breg and Treg frequencies in peripheral blood from Ghanaian uninfected endemic normals (EN), lymphedema (LE), asymptomatic patent (CFA+MF+) and latent (CFA+MF-) W. bancrofti-infected individuals as well as individuals who were previously infected with W. bancrofti (PI) but had cleared the infection due to the administration of ivermectin (IVM) and albendazole (ALB). In summary, we observed that IL-10-producing CD19+CD24highCD38dhigh Breg were specifically increased in patently infected (CFA+MF+) individuals. In addition, CD19+CD24highCD5+CD1dhigh and CD19+CD5+CD1dhighIL-10+ Breg as well as CD4+CD127-FOXP3+ Treg frequencies were significantly increased in both W. bancrofti-infected cohorts (CFA+MF+ and CFA+MF-). Interestingly, the PI cohort presented frequency levels of all studied regulatory immune cell populations comparable with the EN group. In conclusion, the results from this study show that an ongoing W. bancrofti infection induces distinct Breg and Treg populations in peripheral blood from Ghanaian volunteers. Those regulatory immune cell populations might contribute to the regulated state of the host immune system and are probably important for the survival and fertility (microfilaria release) of the helminth.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Unraveling the Dynamics of Human Filarial Infections: Immunological Responses, Host Manifestations, and Pathogen Biology.Pathogens. 2025 Feb 25;14(3):223. doi: 10.3390/pathogens14030223. Pathogens. 2025. PMID: 40137708 Free PMC article. Review.
-
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.PLoS Negl Trop Dis. 2019 May 20;13(5):e0007325. doi: 10.1371/journal.pntd.0007325. eCollection 2019 May. PLoS Negl Trop Dis. 2019. PMID: 31107869 Free PMC article. Clinical Trial.
-
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.PLoS Negl Trop Dis. 2022 Feb 9;16(2):e0010096. doi: 10.1371/journal.pntd.0010096. eCollection 2022 Feb. PLoS Negl Trop Dis. 2022. PMID: 35139070 Free PMC article. Clinical Trial.
-
Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.Acta Trop. 2011 Sep;120 Suppl 1:S33-8. doi: 10.1016/j.actatropica.2010.09.009. Epub 2010 Oct 8. Acta Trop. 2011. PMID: 20933491 Clinical Trial.
-
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.Trop Med Int Health. 2006 May;11(5):718-28. doi: 10.1111/j.1365-3156.2006.01606.x. Trop Med Int Health. 2006. PMID: 16640625 Review.
Cited by
-
Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome.PLoS Negl Trop Dis. 2024 May 9;18(5):e0012076. doi: 10.1371/journal.pntd.0012076. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38722927 Free PMC article. No abstract available.
-
Adoptive Transfer of Immune Cells Into RAG2IL-2Rγ-Deficient Mice During Litomosoides sigmodontis Infection: A Novel Approach to Investigate Filarial-Specific Immune Responses.Front Immunol. 2021 Nov 18;12:777860. doi: 10.3389/fimmu.2021.777860. eCollection 2021. Front Immunol. 2021. PMID: 34868049 Free PMC article.
-
Impact of Helminth Infections on Female Reproductive Health and Associated Diseases.Front Immunol. 2020 Nov 23;11:577516. doi: 10.3389/fimmu.2020.577516. eCollection 2020. Front Immunol. 2020. PMID: 33329545 Free PMC article. Review.
-
Unraveling the Dynamics of Human Filarial Infections: Immunological Responses, Host Manifestations, and Pathogen Biology.Pathogens. 2025 Feb 25;14(3):223. doi: 10.3390/pathogens14030223. Pathogens. 2025. PMID: 40137708 Free PMC article. Review.
-
Harnessing Immune Evasion Strategy of Lymphatic Filariae: A Therapeutic Approach against Inflammatory and Infective Pathology.Vaccines (Basel). 2022 Aug 1;10(8):1235. doi: 10.3390/vaccines10081235. Vaccines (Basel). 2022. PMID: 36016123 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous